Form 4 for IRD Opus Genetics, Inc.
Accepted 2024-05-24 00:00:00 ET · period of report 2024-05-22 · accession 0000905148-24-001625 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-05-24 | 2024-05-22 | IRD | Jayagopal Ashwath | Chief Scientific, Dev. Ofc | P - Purchase | $1.77 | +3,500 | 78.5K | +5% | +$6,195 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-22 | P | A | 3,500 | $1.77 | 78,500 | D | — | — |